Disparities in Fungal Diagnostic Capacity Across Chinese Hospitals: A Nationwide Survey Highlighting Gaps in Molecular Testing and GDP-Linked Inequalities
Mycopathologia · 2025
DOI: 10.1007/s11046-025-00982-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycopathologia, 2025. Verfasst von Ruiqing Tian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venerology, Peking University First Hospital, No. 8 Xishiku Street, Xi Cheng District, Beijing, China. Hauptthemen laut MEDLINE: Mycoses, Hospitals, Molecular Diagnostic Techniques, Diagnostic Tests, Routine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Research Project of Peking University First Hospital.
Abstract (Originalsprache)
BACKGROUND: With the increasing incidence of fungal infection in China, the need for rapid and accurate diagnosis of mycosis is crucial. Therefore, it is necessary to understand the diagnosis capacity for mycosis. METHODS: A cross-sectional online survey was conducted across all 31 provincial-level regions in China from August 2023 to April 2024. The survey comprised 77 questions evaluating fungal diagnostic methods, including culture, microscopy, molecular tests, and related biomarkers. Data from 1,009 valid responses were stratified by hospital tier (tertiary A vs. non-tertiary A) and regional GDP levels to analyze on-site testing capacity and outsourcing patterns. RESULTS: Among the 1,009 respondents, 78.5% were from tertiary A hospitals. Mycology testing was more commonly performed in tertiary hospitals compared to other. Traditional mycological diagnostic methods showed no significant differences in application across regions, regardless of economic development. However, disparities emerged in novel tests, particularly molecular diagnostics: hospitals in low-GDP regions were more likely to outsource molecular testing or lack in-house capacity. CONCLUSIONS: China's fungal diagnostic capacity remains concentrated in tertiary A hospitals and high-GDP regions. Future efforts should prioritize expanding molecular testing access and optimizing resource distribution across all healthcare settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Venerology, Peking University First Hospital, No. 8 Xishiku Street, Xi Cheng District, Beijing, China.
- Research Center for Medical Mycology, Peking University, Beijing, China.
- National Clinical Research Center for Skin and Immune Diseases, Beijing, China.
- Department of Clinical Laboratory, The No.1 Hospital of Baoding, Baoding, Hebei Province, China, Baoding, China.
- Mycology Reference Centre Manchester and Department of Infectious Diseases, Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust and Division of Evolution, Infectio…
- Department of Medical Microbiology and Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, Netherlands.
Förderung
- Research Project of Peking University First Hospital
Zitieren
APA
Tian, R., Bai, Q., Xu, T., Richardson, M., de Hoog, S., Yu, J., Zhou, S., Li, R., & Song, Y. (2025). Disparities in Fungal Diagnostic Capacity Across Chinese Hospitals: A Nationwide Survey Highlighting Gaps in Molecular Testing and GDP-Linked Inequalities. Mycopathologia. https://doi.org/10.1007/s11046-025-00982-2
Vancouver
Tian R, Bai Q, Xu T, Richardson M, de Hoog S, Yu J, et al. Disparities in Fungal Diagnostic Capacity Across Chinese Hospitals: A Nationwide Survey Highlighting Gaps in Molecular Testing and GDP-Linked Inequalities. Mycopathologia. 2025. doi:10.1007/s11046-025-00982-2
BibTeX
@article{Tian2025,
author = {Tian, Ruiqing and Bai, Qianqian and Xu, Tianyi and Richardson, Malcolm and de Hoog, Sybren and Yu, Jin and Zhou, Shaoqin and Li, Ruoyu and Song, Yinggai},
title = {Disparities in Fungal Diagnostic Capacity Across Chinese Hospitals: A Nationwide Survey Highlighting Gaps in Molecular Testing and GDP-Linked Inequalities},
journal = {Mycopathologia},
year = {2025},
doi = {10.1007/s11046-025-00982-2}
}
EUVIMED